Amgen Inc. vs AstraZeneca PLC
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Amgen Inc. and AstraZeneca PLC are worth about the same: $249.2 B and $242.6 B (market caps of Oct 30, 2026 for Amgen Inc. and Aug 1, 2026 for AstraZeneca PLC). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- AstraZeneca PLC had more revenue: $58.7 B against $36.8 B for Amgen Inc., both in the year to December 2025.
- AstraZeneca PLC earned more: net income of $10.2 B against $7.7 B for Amgen Inc.
- Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 17.4% for AstraZeneca PLC.
- AstraZeneca PLC employs more people: 89,900 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $653,382 at AstraZeneca PLC.
- On price to earnings, Amgen Inc. trades at 26.5× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Amgen Inc.'s profit.
- Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against +8.6% for AstraZeneca PLC.
- On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and AstraZeneca PLC 8. Their Altman Z-scores put Amgen Inc. in the grey zone and AstraZeneca PLC in the safe zone.
- Dividend yield: 2.06% for Amgen Inc. and 2.05% for AstraZeneca PLC.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Amgen Inc. AMGN · #73 in the world | AstraZeneca PLC AZN · #76 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇬🇧 UK |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1980 | 1999 |
| Size | ||
| Market cap | $249.2 B | $242.6 B |
| Revenue | $36.8 B | $58.7 B |
| Net income | $7.7 B | $10.2 B▲ best |
| Employees | 25,200 | 89,900 |
| Valuation | ||
| P/E ratio | 26.5× | 23.7× |
| Price to sales | 6.4× | 4.1× |
| Price to book | 28.8× | 5.0× |
| Free cash flow yield | 3.3% | 4.8%▲ best |
| Profitability | ||
| Gross margin | 67.3% | 81.9%▲ best |
| Operating margin | 24.7%▲ best | 23.4% |
| Net margin | 21.0%▲ best | 17.4% |
| Return on equity | 106.1%▲ best | 22.9% |
| Return on invested capital | 14.4% | 17.5%▲ best |
| Growth | ||
| Revenue growth | 9.9%▲ best | 8.6% |
| Revenue growth, 3 years a year | 11.8%▲ best | 9.8% |
| Earnings per share growth | 88.2%▲ best | 45.3% |
| Financial strength | ||
| Debt to equity | 6.3× | 0.5×▲ best |
| Net debt to EBITDA | 3.2× | — |
| Interest cover | 3.3× | 8.1×▲ best |
| Cash | ||
| Free cash flow margin | 22.0%▲ best | 20.0% |
| Shareholder returns | ||
| Dividend yield | 2.1%▲ best | 2.0% |
| Shareholder yield | 2.1% | 2.3%▲ best |
| Strength scores | ||
| Piotroski F-score | 7 of 9 | 8 of 9▲ best |
| Altman Z-score zone | grey | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Amgen Inc. or AstraZeneca PLC?
Amgen Inc. and AstraZeneca PLC are worth about the same: $249.2 B and $242.6 B (market caps of Oct 30, 2026 for Amgen Inc. and Aug 1, 2026 for AstraZeneca PLC). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Amgen Inc. or AstraZeneca PLC?
AstraZeneca PLC had more revenue: $58.7 B against $36.8 B for Amgen Inc., both in the year to December 2025. AstraZeneca PLC earned more: net income of $10.2 B against $7.7 B for Amgen Inc.
Which is more profitable, Amgen Inc. or AstraZeneca PLC?
Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 17.4% for AstraZeneca PLC.
Which has more employees, Amgen Inc. or AstraZeneca PLC?
AstraZeneca PLC employs more people: 89,900 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $653,382 at AstraZeneca PLC.
Is Amgen Inc. cheaper than AstraZeneca PLC?
On price to earnings, Amgen Inc. trades at 26.5× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Amgen Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, Amgen Inc. or AstraZeneca PLC?
Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against +8.6% for AstraZeneca PLC.
Which is financially stronger, Amgen Inc. or AstraZeneca PLC?
On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and AstraZeneca PLC 8. Their Altman Z-scores put Amgen Inc. in the grey zone and AstraZeneca PLC in the safe zone.
More about Amgen Inc.
More about AstraZeneca PLC
Sources#
Every figure on this page comes from these, with the date shown next to it.